ALTERITY THERAPEUTICS-ADR (ATHE) Stock Analyst Ratings
NASDAQ:ATHE • US02155X2053
3.43 USD
-0.01 (-0.29%)
Last: Mar 2, 2026, 11:06 AM
ChartMill assigns a Buy % Consensus number of 80% to ATHE. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 3.37. This target is -1.69% below the current price.
- ATHE was analyzed by 5 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about ATHE.
- In the previous month the buy percentage consensus was at a similar level.
- Only 5 analysts analyzed ATHE. So this is just the average opinion of a couple of analysts.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-12-17 | Canaccord Genuity | Initiate | Speculative Buy |
| 2025-01-30 | Maxim Group | Maintains | Buy -> Buy |
| 2024-12-12 | Maxim Group | Initiate | Buy |
| 2024-03-07 | Benchmark | Reiterate | Speculative Buy -> Speculative Buy |
| 2023-06-05 | Ladenburg Thalmann | Maintains | Buy -> Buy |
| 2022-08-03 | Ladenburg Thalmann | Initiate | Buy |
| 2022-06-23 | Goldman Sachs | Maintains | Neutral |
| 2021-08-20 | Benchmark | Initiate | Speculative Buy |
ALTERITY THERAPEUTICS-ADR / ATHE FAQ
What is the price target for ATHE stock?
5 analysts have analysed ATHE and the average price target is 3.37 USD. This implies a price decrease of -1.69% is expected in the next year compared to the current price of 3.43.
What is the consensus rating for ALTERITY THERAPEUTICS-ADR (ATHE) stock?
The consensus rating for ALTERITY THERAPEUTICS-ADR (ATHE) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for ATHE stock?
The number of analysts covering ALTERITY THERAPEUTICS-ADR (ATHE) is 5.